PRMT5 and leukemia: In leukemia cell lines, the H3R2 and H3R8 symmetrical dimethylation by PRMT5 antagonizes H3K27 trimethylation by PRC2, thus, maintaining the transcription of target genes, resulting in proliferative effects and cell cycle activation [80].